期刊文献+

辅助生殖领域拮抗剂方案标准化应用专家共识 被引量:40

Expert consensus on standardized application of antagonist protocol in assisted reproductive technology
原文传递
导出
摘要 随着辅助生殖技术的飞速发展,寻求高效与安全并重的促排卵方案是辅助生殖医生的不断追求。目前,拮抗剂方案因其诸多优势而受到临床医生的青睐。为促进拮抗剂方案的标准化应用,本共识全面综述了拮抗剂方案使用节点,讨论和解决在拮抗剂的应用上存在的主要问题,为临床医师拮抗剂方案的应用提供指导和建议。 With the rapid development of assisted reproductive technology,it is the continuous pursuit of assisted reproductive doctors to seek an ovarian stimulation protocol with equal emphasis on efficiency and safety.At present,the antagonist protocol is favored by clinicians because of its many advantages.In order to promote the standardized application of the antagonist protocol,this consensus provides a comprehensive overview of use nodes of the antagonist protocol,discuss and solve the main problems in the application of antagonists,provide guidance and suggestions for clinicians in the use of antagonist protocol.
作者 中国女医师协会生殖医学专业委员会专家共识编写组 李蓉 甄秀梅 杨蕊 Expert Consensus Compilation Group of Reproductive Medicine Committee of China Medical Women's Association;Li Rong
出处 《中华生殖与避孕杂志》 CSCD 北大核心 2022年第2期109-116,共8页 Chinese Journal of Reproduction and Contraception
基金 国家重点研发计划(2016YFC1000302) 北京市科技计划课题(Z191100006619085)。
关键词 生殖技术 辅助 受精 体外 单精子显微注射 卵胞质内 促排卵 促性腺激素释放激素拮抗剂 Reproductive technology,assisted Fertilization in vitro Sperm injection,intracytoplasmic Ovarian stimulation Gonadotropin-releasing hormone antagonist
  • 相关文献

参考文献14

二级参考文献199

  • 1胡蓉,宋学茹,夏天.脱氢表雄酮在卵巢储备功能降低患者体外受精-胚胎移植中的应用[J].国际生殖健康/计划生育杂志,2013,32(2):114-117. 被引量:8
  • 2杜乃立,戚文航.外周多巴胺受体激动剂及其应用[J].国外医学(心血管疾病分册),2000,27(3):131-133. 被引量:7
  • 3Fowler PA,Sorsa-Leslie T,Harris W,et al.Ovarian gonadotrophin surge-attenuating factor (GnSAF):where are we after 20 years of research?[J].Reproduction,2003,126(6):689-699.
  • 4Martinez F,Barri PN,Coroleu B,et al.Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles[J].Hum Reprod,2002,17(3):634-640.
  • 5Barri PN,Coroleu B,Martinez F,et al.Stimulation protocols for poor responders and aged women[J].Mol Cell Endocrinol,2000,166(1):15-20.
  • 6Ferraretti,AP,Gianaroli L,Magli MC,et al.Female poor responders[J].Mol Cell Endocrinol,2000,161(1-2):59-66.
  • 7Lidor AL,Cohen SB,Seidman DS,et al.Preferred treatment of infertile women older than 37 years of age who demonstrate premature luteinization in the first evaluation cycle[J].Fertil Steril,2000,73(2):321-324.
  • 8Engel JB,Ludwig M,Felberbaum R,et al.Use of cetrorelix in combination with clomiphene citrate and gooadotrophins:a suitable approach to "friendly IVF" ?[J].Hum Reprod,2002,17(8):2022-2026.
  • 9Lee TH,Lin YH,Scow KM,et al.Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins:a randomized trial[J].Fertil Steril,2008,90(1):113-120.
  • 10Salazar JM,Cerrillo M,Quea G,et al.GnRH antagonist ganirelix prevents premature luteinization in IUI cycles:rationale for its use[J].Reprod Biomed Online,2009,19(2):156-161.

共引文献582

同被引文献212

引证文献40

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部